Mycobacterium tuberculosiscontrols host innate immune activation through cyclopropane modification of a glycolipid effector molecule

• DOI: 10.1084/jem.20041668
• Publication Date: 2005-02-15T01:13:39Z
• Authors: Vivek Rao; Nagatoshi Fujiwara; Steven A. Porcelli; Michael S. Glickman
• Keywords: Cyclopropanes; Mice, Knockout; 0301 basic medicine; Interleukin-6; Tumor Necrosis Factor-alpha; Macrophages; Colony Count, Microbial; Methyltransferases; Mycobacterium tuberculosis; Macrophage Activation; Article; Immunity, Innate; Cell Line; 3. Good health; Mice, Inbred C57BL; Mice; 03 medical and health sciences; Mutation; Animals; Cord Factors; Tuberculosis, Pulmonary

Mycobacterium tuberculosis (Mtb) infection remains a global health crisis. Recent genetic evidence implicates specific cell envelope lipids in Mtb pathogenesis, but it is unclear whether these cell envelope compounds affect pathogenesis through a structural role in the cell wall or as pathogenesis effectors that interact directly with host cells. Here we show that cyclopropane modification of the Mtb cell envelope glycolipid trehalose dimycolate (TDM) is critical for Mtb growth during the first week of infection in mice. In addition, TDM modification by the cyclopropane synthase pcaA was both necessary and sufficient for proinflammatory activation of macrophages during early infection. Purified TDM isolated from a cyclopropane-deficient pcaA mutant was hypoinflammatory for macrophages and induced less severe granulomatous inflammation in mice, demonstrating that the fine structure of this glycolipid was critical to its proinflammatory activity. These results established the fine structure of lipids contained in the Mtb cell envelope as direct effectors of pathogenesis and identified temporal control of host immune activation through cyclopropane modification of TDM as a critical pathogenic strategy of Mtb.